Interim Results

RNS Number : 9746S
Asian Plantations Limited
30 September 2014
 



30 September 2014

 

Asian Plantations Ltd

("APL" or the "Company")

 

Interim Results for the Six Months ended 30 June 2014

 

Asian Plantations Limited (LSE: PALM), a palm oil plantation company with operations in Malaysia, is pleased to announce its unaudited results for the six month period ended 30 June 2014.

 

Highlights

·      US$18.89m of revenue reported (H1 2013: US$0.96m), a significant increase versus the previous period, predominantly from the sale of crude palm oil accounting for US$15,553,000 of total revenue.

 

·      Total assets of US$218.62mm (30 June 2013: US$217.37m)

 

Post-Balance Sheet Events

·      Voluntary conditional cash offer announced on 29 August 2014 from Merrill Lynch (Singapore) Pte Ltd, acting for and on behalf of FELDA Global Ventures Holdings Berhad ("FELDA"), for the entire issued share capital of the Company. FELDA has received irrevocable undertakings to accept the offer in respect of approximately 59.9 per cent. of the Company's currently issued share capital.

 

 

For further information contact:

 

Asian Plantations Limited

Graeme Brown, Joint Chief Executive Officer

Dennis Melka, Joint Chief Executive Officer

 

 

Tel: +65 6325 0970

 

Strand Hanson Limited

James Harris

James Spinney

James Bellman

 

 

Tel: +44 (0) 20 7409 3494

 

 

 

Macquarie Capital (Europe) Limited

Steve Baldwin

 

 

Tel: +44 (0) 203 037 2000

 

Panmure Gordon (UK) Limited

Charles Leigh-Pemberton

Tom Nicholson

 

 

 

Tel: +44 (0) 20 7886 2500

Tel: +65 6824 8204

 

 

 

 

Unaudited Interim Condensed Consolidated Income Statement

for the six-month period ended 30 June 2014

 

 

 




Note

 

 


Six Months

Ended

30.6.2014


Six Months

Ended

30.6.2013






USD'000


USD'000






Unaudited


Unaudited









Revenue



6


18,893


963









Cost of sales



7


(20,495)


(3,444)











Gross loss





(1,602)


(2,481)









Other operating income



8


339


674

Administrative expenses



9


(3,016)


(1,774)

Other operating expenses



10


(733)


(709)









Operating loss





(5,012)


(4,290)









Finance costs



11


(6,070)


(3,622)

















Loss before tax





(11,082)


(7,912)









Income tax benefit



12


470


991

















Loss for the period





(10,612)


(6,921)

























Attributable to :








Owners of the Company





(10,611)


(6,920)

Non-controlling interests





(1)


(1)






















(10,612)


(6,921)

















Loss per share attributable to owners of the Company (cents per share)
















Basic



13


(22.69)


(14.86)









 

 

Diluted



  13


(22.69)


(14.86)









* Amount less than USD1,000

 

 

 

 

Unaudited Interim Condensed Consolidated Statement of Comprehensive Income

for the six-month period ended 30 June 2014

 




Six Months

Ended

30.6.2014


Six Months

Ended

30.6.2013




USD'000


USD'000




Unaudited


Unaudited







Loss for the period



(10,612)


(6,921)







Other comprehensive income






Items that may be reclassified subsequently to profit or loss:






Foreign currency translation adjustments



940


(2,066)















Total comprehensive income for the period, net of tax



 

(9,672)


 

(8,987)













Attributable to:












Owners of the Company



(9,671)


(8,986)

Non-controlling interests



(1)


(1)
















(9,672)


(8,987)



















 

* Amount less than USD1,000

 

 

 

 

Unaudited Interim Condensed Consolidated Statement of Financial Position as at 30 June 2014

 





Note


30.6.2014


31.12.2013







USD'000


USD'000







Unaudited


Audited










ASSETS









Non-current assets









Deferred tax assets






611


511

Property, plant and equipment




14


65,818


63,823

Biological assets




15


75,126


66,994

Land use rights




16


58,063


58,042

Goodwill on consolidation






7,258


7,099

























206,876


196,469



















Current assets









Inventories




17


1,562


1,542

Trade and other receivables






5,798


6,738

Income tax recoverable






35


36

Prepayments






330


1,776

Cash and bank balances






4,017


10,813

























11,742


20,905



















Total assets






218,618


217,374




























EQUITY AND LIABILITIES









Equity









Issued capital




  18


89,731


89,731

Accumulated losses






(44,656)


(34,045)

Other reserves




  19


(11,437)


(12,487)




























Equity attributable to owners of the Company






33,638


43,199










Non-controlling interests






(5)


(4)



















Total equity






33,633


43,195




























Non-current liabilities









Loans and borrowings




20


133,157


129,123

Convertible bonds




21


18,723


17,420

Deferred tax liabilities






5,146


5,430

























157,026


151,973










Current liabilities









Trade and other payables






17,567


14,279

Other current financial liabilities






3,990


3,078

Income tax payable






10


-

Loans and borrowings




20


6,329


4,819

Derivative financial instruments




21


63


30

























27,959


22,206



















Total liabilities






184,985


174,179



















Total equity and liabilities






218,618


217,374



















 

Unaudited Interim Condensed Consolidated Statement of Changes in Equity

for the six-month period ended 30 June 2014

 


Attributable to the owners

of the Company


Non-controlling interests


Total equity

 

 

Share

capital


Other reserves


Accumulated losses


Total




USD'000


USD'000


USD'000


USD'000


USD'000


USD'000













For the six months ended 30.6.2014
























Unaudited












At 1 January 2014

89,731


(12,487)


(34,045)


43,199


(4)


43,195

























Loss for the period

-


-


(10,611)


(10,611)


(1)


(10,612)













Other comprehensive income












Foreign currency translation adjustments

-


940


-


940


-


940

























Total comprehensive income for the period

-


940


(10,611)


(9,671)


(1)


(9,672)













Share-based payment transactions (Note 23)

-


110


-


110


-


110

























At 30 June 2014

89,731


(11,437)


(44,656)


33,638


(5)


33,633













 

 

 


Attributable to the owners

of the Company


Non-controlling interests


Total equity

 

 

Share

capital


Other reserves


Accumulated losses


Total




USD'000


USD'000


USD'000


USD'000


USD'000


USD'000













For the six months ended 30.6.2013
























Unaudited












At 1 January 2013

88,594


(7,916)


(23,645)


57,033


(3)


57,030

























Loss for the period

-


-


(6,920)


(6,920)


(1)


(6,921)













Other comprehensive income












Foreign currency translation adjustments

-


(2,066)


-


(2,066)


-


(2,066)

























Total comprehensive income for the period

-


(2,066)


(6,920)


(8,986)


(1)


(8,987)













Issuance of ordinary shares pursuant to share-based payment plans

1,137


-


-


1,137


-


1,137













Share-based payment transactions (Note 23)

-


(727)


-


(727)


-


(727)

























At 30 June 2013

89,731


(10,709)


(30,565)


48,457


(4)


48,453





































 

 

 

 

Unaudited Interim Condensed Consolidated Statement of Cash Flows

for the six-month period ended 30 June 2014

 



Six Months

Ended

30.6.2014


Six Months

Ended

30.6.2013



USD'000


USD'000



Unaudited


Unaudited






Operating activities





Loss before tax


(11,082)


(7,912)






Non-cash adjustment to reconcile loss before tax to

   net cash flows:





Amortisation of land use rights


558


513

Depreciation of property, plant and equipment


1,628


539

Gain on disposal of property, plant and equipment


-


(6)

Inventories written down to net realisable value


75


-

(Loss)/gain arising from changes in fair value of convertible bonds


33


(420)

Interest income


(71)


(232)

Interest expense


6,070


3,622

Unrealised (gain)/loss on foreign exchange


(226)


168

Share-based payment transaction expense


36


30






Working capital adjustments:





Increase in inventories


(62)


(832)

Decrease/(increase) in trade and other receivables and prepayments


1,685


(48)

Increase in trade and other payables


3,731


585













2,375


(3,993)

Income taxes paid, net of refund


(4)


(20)

Interest received


71


232

Interest paid


(4,544)


(3,066)











Net cash flows used in operating activities


(2,102)


(6,847)











Investing activities










Proceeds from disposal of property, plant and equipment


-


6

Purchase of property, plant and equipment


(2,163)


(11,884)

Refund for over payment of land use rights in previous years


707


-

Additions to biological assets


(5,693)


(5,869)

Partial settlement of purchase price for subsidiary acquired in previous year


(53)


-











Net cash flows used in investing activities


(7,202)


(17,747)






 

 

Financing activities










 

Proceeds from issuance of ordinary shares


-


311

 

Proceeds from issuance of convertible bond


-


4,897

 

Issuance expense on liability component of convertible bond


-


(522)

 

Repayment of short term revolving credit


-


(1,888)

 

Repayment of term loans


(860)


(39,705)

 

Proceeds from term loans


3,418


3,557

 

Proceeds from Bank Guaranteed Medium Term Notes Programme


-


48,192

 

Repayment of finance lease liabilities


(310)


(257)

 

Short-deposits pledged for a banking facility and supply of goods


 

(23)


 

79

 






 






 

Net cash flows from financing activities


2,225


14,664

 






 






 

Net decrease in cash and cash equivalents


(7,079)


(9,930)

 

Net foreign exchange difference


62


8

 

Cash and cash equivalents at 1 January


7,473


14,188

 






 






 

Cash and cash equivalents at 30 June (Note 22)


456


4,266

 






 

 

 

 

Notes to the Unaudited Interim Condensed Consolidated Financial Statements - 30 June 2014

 

1.         Corporate information

 

The interim condensed consolidated financial statements of Asian Plantations Limited (the "Company") and its subsidiaries (collectively, the "Group") for the six months ended 30 June 2014 were authorised for issue in accordance with a resolution of the directors on 30 September 2014.

 

Asian Plantations Limited is a limited liability company incorporated and domiciled in the Republic of Singapore and listed on the Alternative Investment Market ("AIM") of the London Stock Exchange.

 

The registered office of the Company is located at No.14 Ann Siang Road, #02-01, Singapore 069694.

 

The principal activity of the Company is that of investment holding. The principal activities of the subsidiaries are development of oil palm plantation and operating of an oil palm mill. 

 

 

2.         Basis of preparation and changes to the Group's accounting policies

 

Basis of preparation

 

The interim condensed consolidated financial statements for the six months ended 30 June 2014 have been prepared in accordance with IAS 34 Interim Financial Reporting.

 

The interim condensed consolidated financial statements are unaudited and do not include all the information and disclosures required in the annual financial statements, and should be read in conjunction with the Group's annual financial statements as at 31 December 2013.

 

The financial statements are presented in United States Dollars ("USD") to facilitate the comparison of financial results with companies in the oil-palm industry and all values are rounded to the nearest thousand ("USD'000") except when otherwise indicated.

 

New standards, interpretations and amendments adopted by the Group

 

The accounting policies adopted in the preparation of the interim condensed consolidated financial statements are consistent with those followed in the preparation of the Group's annual financial statements for the year ended 31 December 2013.

 

 

3.         Significant accounting judgements and estimates

 

The preparation of the consolidated financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the disclosure of contingent liabilities at the end of the reporting period. However, uncertainty about these assumptions and estimates could result in outcomes that could require a material adjustment to the carrying amount of the asset or liability affected in the future periods.

 

3.1       Judgements made in applying accounting policies

 

In the process of applying the Group's accounting policies, management has made the following judgements, apart from those involving estimations, which has the most significant effect on the amounts recognised in the consolidated financial statements:

 

(a)        Fair value of biological assets (nursery)

 

Nurseries are stated at fair value. Management made the judgement that cost approximates fair value of the biological asset for nursery because little biological transformation has taken place since its initial cost incurrence. The carrying amount of nursery as at 30 June 2014 was USD2,362,000 (31 December 2013: USD1,294,000). 

 

(b)        Fair value of biological assets (mature and immature plantations)

 

Mature and immature plantations are stated at fair value. Management adopts the practice of determining the fair value of the mature and immature plantations of the Group on an annual basis. Management is of the view that changes in fair value of mature and immature plantations as at 30 June 2014 would not materially differ from 31 December 2013 as there are no changes to the key assumptions in the biological asset valuation model. The carrying amount of mature and immature plantations as at 30 June 2014 was USD72,764,000 (31 December 2013: USD65,700,000). 

 

3.2       Estimates and assumptions

 

The key assumptions concerning the future and other key sources of estimation uncertainty at the reporting date, that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are described below. The Group based its assumptions and estimates on parameters available when the consolidated financial statements were prepared. Existing circumstances and assumptions about future developments, however, may change due to market changes or circumstances arising beyond the control of the Group. Such changes are reflected in the assumptions when they occur.

 

(a)        Useful lives of property, plant and equipment

 

There are no changes to the estimated economic useful life of property, plant and equipment of within 5 to 60 years.

 

(b)        Impairment of goodwill

 

An impairment exists when the carrying value of an asset or cash generating unit exceeds its recoverable amount, which is the higher of its fair value less costs to sell and its value in use. The value in use calculation is based on a discounted cash flow model. The cash flows are derived from projected net cash flows over a period of 25 productive years of oil palms from financial budgets approved by management and do not include restructuring activities that the Group is not yet committed to or significant future investments that will enhance the asset's performance of the cash generating unit being tested. Based on management's analysis, goodwill is not impaired as at 30 June 2014.

 

(c)        Taxes

 

Uncertainties exist with respect to the interpretation of complex tax regulations, changes in tax laws, and the amount and timing of future taxable income. Given the wide range of international business relationships and the long-term nature and complexity of existing contractual agreements, differences arising between the actual results and the assumptions made, or future changes to such assumptions, could necessitate future adjustments to tax income and expense already recorded. The Group establishes provisions, based on reasonable estimates, for possible consequences of audits by the tax authorities of the respective counties in which it operates. The amount of such provisions is based on various factors, such as experience of previous tax audits and differing interpretations of tax regulations by the taxable entity and the responsible tax authority. Such differences of interpretation may arise on a wide variety of issues depending on the conditions prevailing in the respective company's domicile.

 

The carrying amount of income tax recoverable at 30 June 2014 was USD35,000 (31 December 2013: USD36,000).

 

Deferred tax assets are recognised for all unused tax losses, unabsorbed capital and agricultural allowances to the extent that it is probable that taxable profit will be available against which the losses, unabsorbed capital and agricultural allowances can be utilised. Significant management judgement is required to determine the amount of deferred tax assets that can be recognised, based upon the likely timing and the level of future taxable profits together with future tax planning strategies.

 

 

4.         Seasonality of operations

 

The Group's plantation operations are affected by seasonal crop production, weather conditions and fluctuating commodity prices. As a result, the comparison of half-year to half-year results may not be a good indicator of the overall trend of the Group's plantation operations or of the results for the whole of the financial period. 

 

 

5.         Segment information

 

The following tables present revenue and profit information about the Group's operating segments for the six months ended 30 June 2014 and 2013, respectively:

 

 

 

Six months ended

30 June 2014


Plantation activities


Oil palm milling activities


Investment holding


Total segments


Adjustments and eliminations


Consolidated

Unaudited


USD'000


USD'000


USD'000


USD'000


USD'000


USD'000














Revenue













External customers


878


18,015


-


18,893


-


18,893

Inter-segment


1,973


-


-


1,973


(1,973)


-



























Total revenue


2,851


18,015


-


20,866


(1,973)


18,893



























Results


























Segment loss


(4,877)


(2,890)


(771)


(8,538)


-


(8,538)



























 

Inter-segment revenues of USD1,973,000 are eliminated on consolidation.

 

 

Six months ended

30 June 2013


Plantation activities


Oil palm milling activities


Investment holding


Total segments


Adjustments and eliminations


Consolidated

Unaudited


USD'000


USD'000


USD'000


USD'000


USD'000


USD'000














Revenue













External customers


824


139


-


963


-


963

Inter-segment


419


-


-


419


(419)


-



























Total revenue


1,243


139


-


1,382


(419)


963



























Results


























Segment loss


(5,230)


(421)


(1,222)


(6,873)


-


(6,873)



























 

Inter-segment revenues of USD419,000 are eliminated on consolidation

 

 

The following table presents segment assets and liabilities of the Group's operating segments as at 30 June 2014 and 31 December 2013:

 



Plantation activities


Oil palm milling activities


Investment holding


Total segments


Adjustments and eliminations


Consolidated



USD'000


USD'000


USD'000


USD'000


USD'000


USD'000

Segment assets


























30 June 2104

(Unaudited)


176,901


32,069


75,545


284,515


(73,801)


210,714



























31 December 2013

(Audited)


170,877


34,598


76,817


282,292


(72,564)


209,728



























Segment liabilities


























30 June 2014

(Unaudited)


137,274


34,212


5,710


177,196


(62,925)


114,271



























31 December 2013

(Audited)


137,021


34,886


5,084


176,991


(72,564)


104,427














 

 

            Adjustments and eliminations

 

Interest income, certain finance costs and gain arising from changes in fair value of embedded derivative of the convertible bonds are not allocated to individual segments as the underlying instruments are managed on a group basis.

 

Current taxes, deferred taxes, share-based payment transaction expense, goodwill on consolidation and certain liabilities are not allocated to those segments as they are also managed on a group basis.

 

Capital expenditure consists of additions to property, plant and equipment, biological assets and land use rights.

 

Inter-segment revenues are eliminated on consolidation.

 

 


Six Months

Ended

30.6.2014


Six Months

Ended

30.6.2013

 


USD'000


USD'000

 


Unaudited


Unaudited

 





 

Reconciliation of loss before tax




 





 

Segment loss

(8,538)


(6,873)

 

Interest income

71


232

 

Interest expense

(2,579)


(1,689)

 

Share-based payment transaction

(3)


(2)

 

(Loss)/gain arising from changes in fair value of embedded derivative of the convertible bonds

(33)


420

 





 





 

Group loss

(11,082)


(7,912)

 





 





 

 

 





30.6.2014


31.12.2013

Reconciliation of assets

USD'000


USD'000





Segment assets

210,714


209,728

Deferred tax assets

611


511

Goodwill arising on consolidation

7,258


7,099

Income tax recoverable

35


36









Total assets

218,618


217,374









 

 


30.6.2014


31.12.2013


USD'000


USD'000

Reconciliation of liabilities

Unaudited


Audited





Segment liabilities

114,271


104,427

Deferred tax liabilities

5,146


5,430

Loans and borrowings

46,772


46,872

Income tax payable

10


-

Derivative financial instruments

63


30

Convertible bonds

18,723


17,420









Total liabilities

184,985


174,179





 

 

6.         Revenue

 

           



Six Months

Ended

30.6.2014


Six Months

Ended

30.6.2013



USD'000


USD'000






Sale of crude palm oil ("CPO")


15,553


-

Sale of palm kernel ("PK")


2,462


-

Sale of fresh fruit bunches ("FFBs")


878


963













18,893


963






 

7.         Cost of sales

 



Six Months

Ended

30.6.2014


Six Months

Ended

30.6.2013



USD'000


USD'000



Unaudited


Unaudited






Cost of sales for oil palm:





Estates


3,177


3,365

Mill


17,318


79













20,495


3,444






 

 

Included in cost of sales is share-based payment transaction expense of USD33,000 (six months ended 30 June 2013: USD27,000) related to the Company's share option scheme.

 

 

8.         Other operating income

 



Six Months

Ended

30.6.2014


Six Months

Ended

30.6.2013



USD'000


USD'000



Unaudited


Unaudited






Short term deposits interest income


71


232

Sale of seedlings


2


-

Gain arising from changes in fair value of embedded derivative of the convertible bonds


-


420

Gain on disposal of property, plant and equipment


-


6

Other income


266


16













339


674






 

 

9.         Administrative expenses

 

Included in administrative expenses are audit, tax, legal and other professional fees amounting to USD1,893,000 (six months ended 30 June 2013: USD542,000) and share-based payment transaction expense of USD3,000 (six months ended 30 June 2013: USD3,000) related to the Company's share option scheme. 

 

 

10.       Other operating expenses

 



Six Months

Ended

30.6.2014


Six Months

Ended

30.6.2013



USD'000


USD'000



Unaudited


Unaudited






Net foreign exchange loss


-


113

Repair and maintenance


66


75

Amortisation of land use rights


558


513

Inventories written down to net realisable value


75


-

Cost of seedlings sold


1


8

Loss arising from changes in fair value of embedded derivative of the convertible bonds


33


-








733


709






 

 

11.       Finance costs

 



Six Months

Ended

30.6.2014


Six Months

Ended

30.6.2013



USD'000


USD'000



Unaudited


Unaudited






Interest expense on loans and borrowings


4,440


3,016

Interest expense on convertible bonds


198


88

Accretion of interest on convertible bonds


1,294


518

Other interest expense


138


-








6,070


3,622






 

 

12.       Income tax benefit

 

The major components of income tax benefit in the interim consolidated income statement are:

 



Six Months

Ended

30.6.2014


Six Months

Ended

30.6.2013



USD'000


USD'000



Unaudited


Unaudited






Current income tax expense


-


32

Deferred income tax expense related to origination and reversal of deferred taxes


(485)


(1,095)

Under provision of income tax expense in prior period


15


-

Under provision of deferred tax expense in prior period


-


72






Total income tax benefit


(470)


(991)






 


13.       Loss per share

 

Basic loss per share amounts are calculated by dividing loss for the period, net of tax, attributable to owners of the Company by the weighted average number of ordinary shares outstanding during the financial period.

 

Diluted loss per share amounts are calculated by dividing loss for the period, net of tax, attributable to owners of the Company by the weighted average number of ordinary shares outstanding during the financial period plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. There are no dilutive potential ordinary shares as at period ended 30 June 2014 and 2013.

 

 

13.       Loss per share (cont'd)

 

The following tables reflect the loss and share data used in the computation of basic loss and diluted per share for the periods ended 30 June:

 



Six Months

Ended

30.6.2014


Six Months

Ended

30.6.2013



USD'000


USD'000



Unaudited


Unaudited






Loss, net of tax, attributable to owners of the Company


(10,611)


(6,920))

-












No. of shares


No. of shares



'000


'000






Weighted average number of ordinary shares for basic and diluted loss per share computation*


46,761


46,564

-





 

*     The weighted average number of ordinary shares takes into account the weighted average effect of changes in ordinary shares transactions during the period.

 

The potential ordinary shares from unsecured convertible bonds and options granted pursuant to the Company's share option scheme have not been included in the calculation of diluted loss per share because they are anti-dilutive.

 

 

14.       Property, plant and equipment

 



30.6.2014


31.12.2013



USD'000


USD'000



Unaudited


Audited






At 1 January


63,823


53,227

Additions


3,096


18,117

Depreciation


(2,529)


(3,220)

Exchange differences


1,428


(4,301)











At 30 June / 31 December


65,818


63,823
















 

See Note 25(a) for capital commitments.

 

Capitalised borrowing costs

 

The amount of borrowing costs capitalised during the period ended 30 June 2014 was USD10,000 (31 December 2013: USD786,000).

 

 

14.       Property, plant and equipment (cont'd)

 

Depreciation capitalised to biological assets

 

Depreciation of property, plant and equipment of the Group capitalised to biological assets for the financial period ended 30 June 2014 amounted to USD901,000 (31 December 2013: USD1,712,000).

 

Assets under construction

 

Included in property, plant and equipment are assets under construction amounted to USD5,774,000 (31 December 2013: USD16,853,000). The Group's assets under construction mainly includes a palm oil mill, a biogas plant, workers quarters, terraces, roads and bridges/culverts.

 

 

15.       Biological assets

 



30.6.2014


31.12.2013



USD'000


USD'000



Unaudited


Audited

At fair value less cost to sell










At 1 January


66,994


55,287

Additions


6,678


12,867

Gain arising from changes in fair value


-


3,183

Exchange differences


1,454


(4,343)











At 30 June / 31 December


75,126


66,994











Represented by:





Mature plantation


41,660


40,750

Immature plantation


31,104


24,950

Nursery


2,362


1,294











At 30 June / 31 December


75,126


66,994









 

As disclosed in Note 3.1(b), there is no gain or loss arising from changes in fair value less estimated costs to sell during the financial period ended 30 June 2014 (31 December 2013: USD3,183,000) as the Group has adopted the practice of determining and accounting for the fair value changes to its biological assets on an annual basis.

 



30.6.2014


31.12.2013



Hectares


Hectares

Planted area:





Mature plantation


4,507


4,507

Immature plantation


7,654


7,654











Total


12,161


12,161






 

 

16.       Land use rights

 



30.6.2014


31.12.2013



USD'000


USD'000



Unaudited


Audited






At 1 January


58,042


53,517

Additions


-


9,141

Refund for over-payment in previous years


(707)


-

Amortisation charge


(558)


(1,002)

Exchange differences


1,286


(3,614)











At 30 June / 31 December


58,063


58,042






 

Land use rights of the Group are pledged for banking facilities as disclosed in Note 20.

 

 

17.       Inventories

 



30.6.2014


31.12.2013



USD'000


USD'000



Unaudited


Audited






Crude palm oil


166


223

Palm kernel


71


72

Chemicals and fertilisers


856


729

Consumables


469


518













1,562


1,542






 

 

18.       Issued capital

 



30.6.2014


31.12.2013



No. of shares




No. of shares





'000


USD'000


'000


USD'000



Unaudited


Unaudited


Audited


Audited










At 1 January 2014 / 1 January 2013


46,761


89,731


46,511


88,594

Issuance during the period/year


-


-


250


1,137








 

 






At 30 June 2014 / 31 December 2013


46,761


89,731


46,761


89,731












-


-


-


-

 

 

19.       Other reserves

 

The composition of other components of other reserves is as follows:

 


30.6.2014


31.12.2013


USD'000


USD'000


Unaudited


Audited





Merger reserve

(20,256)


(20,256)

Foreign currency translation reserve

(1,273)


(2,213)

Share-based payment transaction reserve

10,092


9,982










(11,437)


(12,487)





 

 

20.       Loans and borrowings

 



30.6.2014


31.12.2013



USD'000


USD'000



Unaudited


Audited






Bank overdraft


2,678


2,477

Term loans


56,508


52,741

Bank Guaranteed Medium Term Notes Programme


78,402


76,607













137,588


131,825






Add: Obligations under finance leases (Note 25)


1,898


2,117











Total loans and borrowings


139,486


133,942











 

Loans and borrowings of the Group are secured either by a charge over the leased assets or leasehold land of the Group in which it has prepaid the rights to use the land as disclosed in Note 16.

 

The Group has secured a temporary relaxation from Malayan Banking Berhad to allow the Group up to 31 December 2014 to comply with the loan covenants for the Bank Guaranteed Medium Term Notes.

 

 

21.       Convertible bonds - Unsecured

 


30.6.2014


31.12.2013


USD'000


USD'000


Unaudited


Audited





Face value of the convertible bonds

17,100


17,100

Less: Embedded derivative

(1,017)


(1,017)

Less: Transaction costs on liability component

(571)


(571)









Liability component at initial recognition

15,512


15,512

Add: Accretion of interest on the convertible bonds

3,211


1,904

Add: Exchange differences

-


4






18,723


17,420





 

 





30.6.2014


31.12.2013

Face value


Maturity


USD'000


USD'000





Unaudited


Audited








USD2.1 million


8 August 2015


2,428


2,273

USD15.0 million


14 January 2016


16,295


15,147



















18,723


17,420








 

Embedded derivative relating to the conversion option of the convertible bond is recorded as a "fair value through profit or loss" financial instrument with a balance of USD63,000 as at 30 June 2014 (31 December 2013: USD30,000).

 

The Group has obtained a waiver from OCBC Capital Investment I Pte. Ltd. on the requirement to meet the covenants specified for the USD15.0 million convertible bonds.

 

 

22.       Cash and bank balances

 

For the purpose of the interim condensed consolidated statement of cash flows, cash and cash equivalents comprise:

 


30.6.2014


31.12.2013


USD'000


USD'000


Unaudited


Audited





Cash and short-term deposits

4,017


10,813

Less: Short-term deposits pledged

(883)


(863)

Less: Bank overdraft

(2,678)


(2,477)










456


7,473





 

 

 

 

23.       Share-based payment plans

 

There has been no cancellation or modification to the Scheme during the period ended 30 June 2013.

 

Expense recognised for this equity-settled share-based payment transaction during the financial period amount to USD110,000 (30 June 2013: USD101,000), of which USD75,000 (30 June 2013: USD71,000 ) has been capitalised to biological assets.

 

            There was no new share options granted nor were there any share options exercised during the financial period.

 

 

24.       Fair value of assets and liabilities

 

(a)        Fair value hierarchy

 

The Group categories fair value measurements using a fair value hierarchy that is dependent on the valuation inputs used as follows:

 

-        Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities that the Group can access at the measurement date,

 

-        Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, and

 

-        Level 3 - Unobservable inputs for the asset or liability.

 

Fair value measurements that use inputs of different hierarchy levels are categorised in its entirety in the same level of the fair value hierarchy as the lowest level input that is significant to the entire measurement.

 

 

(b)        Assets and liabilities measured at fair value

 

The following table shows an analysis of each class of assets and liabilities measured at fair value at the end of the reporting period:

 

 


Quoted prices in active markets for identical instruments


Significant other observable inputs


Significant unobservable inputs


Total


(Level 1)


(Level 2)


(Level 3)



Group

US$'000


US$'000


US$'000


US$'000









30.6.2014








Unaudited








Recurring fair value measurements:















Assets
















Non-financial assets
















Biological assets

-


-


75,126


75,126

















Liabilities
















Financial liabilities
















Embedded derivatives within convertible bonds

-


63


-


63

























31.12.2013








Audited








Recurring fair value measurements:















Assets
















Non-financial assets
















Biological assets

-


-


66,994


66,994

















Liabilities
















Financial liabilities
















Embedded derivatives within convertible bonds

-


30


-


30









 

 

(c)        Level 3 fair value measurements

 

(i)        Information about significant unobservable inputs used in Level 3 fair value measurements

 

As disclosed in Note 3.1(b) and Note 15, the Group has adopted the practice of determining the fair value of its biological assets on an annual basis. Management is of the view that there is no significant change in the key assumptions used in the biological asset valuation model.

 

The following table shows the information about fair value measurements using significant unobservable inputs (Level 3) for biological assets as at 31 December 2013:

 

Description

Fair value

(US$'000)


Valuation techniques


Unobservable inputs


Range


Biological assets

66,994


Discounted cash flow


Discount rate


9.5% - 10.5%














Projected selling price of CPO


USD868 per tonne














FFB yield


0.0 - 21.6

tonnes per hectare









 

For biological assets, a significant increase/(decrease) in discount rate would result in a significantly lower/(higher) fair value. Changes in projected selling price of CPO and FFB yield will result in directionally similar changes in fair value.

 

(ii)        Movements in Level 3 assets measured at fair value

 

The movements in biological assets measured at fair value are disclosed in Note 15.

 

(iii)       Valuation policies and procedures

 

To determine the fair value of biological assets, the Group engages external valuation experts to perform the valuation. The corporate finance team is responsible for selecting and engaging valuation experts that possess the relevant credentials and knowledge on the subject of valuation, valuation methodologies, and IFRS 13 fair value measurement guidance.

 

The corporate finance team reviews the appropriateness of the valuation methodologies and assumptions adopted by the external valuation experts. The corporate finance team also evaluates the appropriateness and reliability of the inputs (including those developed internally by the Group) used in the valuations.

 

Significant changes in fair value measurements from period to period are evaluated by the corporate finance team for reasonableness. Key drivers of the changes are identified and assessed for reasonableness against relevant information from independent sources, or internal sources if necessary and appropriate.

 

(d)        Assets and liabilities not carried at fair value but for which fair value is disclosed

 

The following table shows an analysis of the assets and liabilities not measured at fair value but for which fair value is disclosed:

 


Fair value measurements at the end of the

reporting period using


Group

Quoted prices in active market for identical instruments


Significant other observable inputs


Significant unobservable inputs


Total


Carrying amount


(Level 1)


(Level 2)


(Level 3)






US$'000


US$'000


US$'000


US$'000


US$'000

30.6.2014










Unaudited










Liabilities




















Loans and borrowings










Obligations under finance leases

-


-


1,871


1,871


1,898











Bank Guarantee Medium Term Notes Programme

-


-


79,717


79,717


78,402































31 December 2013










Audited










Liabilities




















Loans and borrowings










Obligations under finance leases

-


-


2,098


2,098


2,117











Bank Guarantee Medium Term Notes Programme

-


-


77,775


77,775


76,607





















 

(d)        Assets and liabilities not carried at fair value but for which fair value is disclosed (cont'd)

 

Determination of fair value

 

The following table shows the significant unobservable inputs and the valuation techniques used in determining the fair value of of the assets and liabilities not measured at fair value but for which fair value is disclosed:

 

Description

Fair value

(US$'000)


Valuation techniques


Unobservable inputs


Range


Obligations under finance lease

1,871


Discounted cash flow


Discount rate


2.50% - 3.30%

















Bank Guarantee Medium Term Notes Programme

77,775


Discounted cash flow


Discount rate


4.09% - 4.30%

















 

 

(e)        Fair value of financial instruments by classes that are not carried at fair value and whose carrying amounts are not reasonable approximation of fair value

 

The fair value of financial assets and liabilities by classes that are not carried at fair value and whose carrying amounts are not reasonable approximation of fair value are as follows:

 


30.6.2014


31.12.2013

-

 

Carrying amount


Fair value


Carrying amount


Fair value


USD'000


USD'000


USD'000


USD'000


Unaudited


Unaudited


Audited


Audited









Financial liabilities
















Loans and borrowings








- Obligations under finance leases

1,898


1,871


2,117


2,098

- Convertible bonds

18,723


*


17,420


*

- Bank Guarantee Medium Term Notes Programme

78,402


79,717


76,607


77,775

















*     Convertible bonds

It is not practicable and cost outweighs benefits to determine the fair value of the unquoted convertible bonds

 

 

25.       Commitments and contingencies

 

(a)        Capital commitments

 

Capital commitments contracted for at the end of the reporting period but not recognised in the financial statements are as follows:

 



30.6.2014


31.12.2013



USD'000


USD'000



Unaudited


Audited






Approved and contracted for:





-    property, plant and equipment


3,929


5,878






Approved and not contracted for:





-    property, plant and equipment


13,197


9,221

-    biological assets


7,900


4,093













25,026


19,192











 

(b)        Operating lease commitments

 

As lessee

 

In addition to the land use rights disclosed in Note 16, the Group has no other operating leases.

 

(c)        Finance leases

 

As lessee

 

The Group has finance leases for certain property, plant and equipment. These leases have terms of renewal but no purchase options and escalation clauses. Renewals are at the option of the specific entity that holds the lease.

 

Future minimum lease payments under finance leases together with the present value of the net minimum lease payments are as follows:

 

(d)        Finance leases (cont'd)

 


30.6.2014


31.12.2013


Minimum lease payments


Present value of minimum lease payments


Minimum lease payments


Present value of minimum lease payments


USD'000


USD'000


USD'000


USD'000


Unaudited


Unaudited


Audited


Audited









Not later than one year

732


634


724


610

Later than one year but not more than five years

1,351


1,264


1,630


1,507

















Total minimum lease payments

2,083


1,898


2,354


2,117

Less: Amount representing finance charges

(185)


-


(237)


-

















Present value of minimum lease payments

1,898


1,898


2,117


2,117









 

 

26.       Related party disclosures

 

The following are the significant transactions between the Group and related parties (who are not members of the Group) that took place during the financial period ended 30 June 2014 and 30 June 2013 at the terms agreed between the parties, which are conducted at mutually agreed terms between the parties.

 



Six Months

Ended


Six Months

Ended



30.6.2014


30.6.2013



USD'000


USD'000



Unaudited


Unaudited






Transactions with related parties





- Rental expenses


26


29

- Administrative costs charged


111


88













137


117


















30.6.2014


30.12.2013



USD'000


USD'000



Unaudited


Audited






Amount due from related parties


23


1











Amount due to related parties


768


150






 

Amount due from/(to) related parties are non-trade related, unsecured, non-interest bearing and are repayable in cash on demand.

 

Related parties represent companies in which certain directors of the Group have financial interest and are also directors of these companies.

 

Compensation of key management personnel

 

 



Six Months

Ended


Six Months

Ended



30.6.2014


30.6.2013



USD'000


USD'000



Unaudited


Unaudited






Directors' salaries


238


241

Directors' fees


92


95

Short term employee benefits


176


174

Contribution to defined contribution plans


22


22

Share-based payment transactions (Note 23)


42


38













570


570











 

 

Compensation of key management personnel (cont'd)

 



Six Months

Ended


Six Months

Ended



30.6.2014


30.6.2013



USD'000


USD'000



Unaudited


Unaudited






Compensation comprise

 





Amounts paid to:





- Directors of the Company


327


333

- Directors of a subsidiary company


3


3

- Other key management personnel


198


196













528


532











Share-based payment transactions expense:





- Other key management personnel


42


38


















570


570






 

The amounts disclosed above are the amounts recognised as an expense during the reporting period related to key management personnel.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR URVBRSNAKORR
UK 100

Latest directors dealings